DES MOINES, Iowa, Nov. 28, 2017 /PRNewswire/ — Today the Iowa Department of Public Health issued a notice of intent to award a manufacturing license to manufacture medical cannabidiol in Iowa to MedPharm Iowa, LLC.

MedPharm Iowa will innovate, manufacture and formulate medical cannabidiol. The Iowa-based company will be obtaining intellectual property from MedPharm Colorado, a Denver-based company specializing in phytopharmaceuticals. The newly formed Iowa company is owned by Dr. Chris Nelson, President and CEO of Kemin Industries, a global ingredient company headquartered in Des Moines, Iowa.

“With the creation of MedPharm Iowa, we will use our innovative expertise and experience with scientifically sound research to assist those dealing with chronic pain, cancer, debilitating diseases and possibly help alleviate the opioid epidemic in Iowa,” said Dr. Nelson. “For more than five decades, the Nelson family has owned and operated Kemin, and we have dedicated our careers to improving the quality of life for billions of people around the world.”

Guided by the expertise of Dr. Nelson, MedPharm Iowa will work to standardize the extraction and manufacturing processes, add scientific rigor to innovation and serve an unmet need in the Iowa market for medical cannabidiol. MedPharm Iowa will have an agreement in place with Kemin to contract for a range of services. The company will have a state-of-the-art growing and manufacturing facility located on the Kemin campus in Des Moines, and will be investing millions of dollars into the state of Iowa.

“The Nelson family believes the answers to the world’s problems exist in nature and science, and we are determined to find those solutions with extensive research and thoughtful product development,” said Dr. Nelson. “I believe botanicals, including the cannabis plant, offer endless possibilities. It is only with innovative vigor and established good manufacturing practices that such botanicals can make an impact to improve lives. MedPharm Iowa aspires to improve the quality of life for those in Iowa who seek natural, scientifically proven solutions to improve daily life when dealing with debilitating medical conditions.”

According to Iowa law, MedPharm Iowa must start supplying medical cannabidiol by December 1, 2018.

About MedPharm Iowa

MedPharm Iowa is a newly formed company that will innovate, manufacture and formulate medical cannabidiol for delivery in Iowa. MedPharm Iowa is dedicated to manufacturing high-quality products and solutions for Iowans dealing with debilitating medical conditions.

About Kemin Industries

Kemin (www.kemin.com) has been dedicated to using applied science to improve the quality of life for over half a century. As a global company touching 3.8 billion people every day with its products, Kemin is committed to improving the quality, safety and efficacy of food, feed and health-related products to feed a growing population and be a resource for others in need.

Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where over 500 specialty ingredients are made for humans and animals in the global feed and food industries, as well as the health, nutrition and beauty markets. The company provides product solutions and options to customers in more than 120 countries.

A privately held, family-owned and operated company, Kemin has more than 2,500 global employees and operates in 90 countries including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, Singapore, South Africa and the United States.